NASDAQ · Financial Statements
Amgen Inc. (AMGN) Financial Statements
$432.49
NASDAQ: AMGN
Market Cap $233.82B
Overview Financials Dividend Amgen Inc. most recently reported annual revenue of $36.7B, net profit of $7.7B. Revenue grew at an average annual rate of 7.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $26.0B $26.3B $28.2B $33.4B $36.7B Operating Profit $7.6B $9.6B $7.9B $7.3B $10.7B Net Profit $5.9B $6.6B $6.7B $4.1B $7.7B EPS $10.28 $12.11 $12.49 $7.56 $14.23 Op Margin 29.4% 36.3% 28.0% 21.7% 29.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $61.2B $65.1B $97.2B $91.8B $90.6B Total Liabilities $54.5B $61.5B $90.9B $86.0B $81.9B Cash $8.0B $7.6B $10.9B $12.0B $9.1B Borrowings $33.3B $38.9B $64.6B $60.1B $54.6B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $9.3B $9.7B $8.5B $11.5B $10.0B Investing Cash Flow $-147.0M $-7.0B $-27.3B $-2.1B $-3.8B Financing Cash Flow $-5.1B $-6.5B $-72.0M $-324.0M $-52.0M Net Cash Flow $1.7B $-360.0M $3.3B $1.0B $-2.8B Free Cash Flow $8.4B $8.8B $7.4B $10.4B $8.1B
Valuation & Return Ratios
Metric Value PEG Ratio 0.81 EV / EBITDA 16.18 FCF Yield 4.55% Quick Ratio 1.13 Interest Coverage 4.74 Return 1Y 50.26% Return 3Y 66.36% Return 5Y 133.80%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .